Skip to main content
. 2017 Sep 22;14(6):6433–6440. doi: 10.3892/ol.2017.7029

Figure 2.

Figure 2.

Representative cell viability profile of CD44+/CD24 breast cancer stem cells non-treated or treated with 100, 300, 500, 750 and 1,000 nM flavopiridol subsequent to (A) 24, (B) 48 and (C) 72 h of incubation. Each concentration was studied as three replicates.